SOPHiA GENETICS (SOPH) Raw Materials (2020 - 2021)
SOPHiA GENETICS (SOPH) reported Raw Materials of $5.1 million for Q4 2021, up 57.17% on a YoY basis from $3.2 million in Q4 2020, and up 57.17% sequentially from $3.2 million in Q4 2020.
SOPHiA GENETICS (SOPH) Raw Materials (2020 - 2021) Analysis & Trends
SOPHiA GENETICS (SOPH) has 2 years of Raw Materials data on file, last reported at $5.1 million in Q4 2021.
- For the quarter ending Q4 2021, Raw Materials rose 57.17% year-over-year to $5.1 million; the trailing twelve-month figure through Dec 2021 stood at $5.1 million (up 57.17% YoY), and the FY2021 full-year result was $5.1 million, up 57.17% from the prior year.
- Raw Materials grew to $5.1 million in Q4 2021, from $3.2 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $5.1 million in Q4 2021 to a low of $3.2 million in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 31.59 Bn | 24.28 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.75 Bn | 13.85 Bn | 482.22 Mn |
| 3 | Healthequity | 8.24 Bn | 7.98 Bn | 256.31 Mn |
| 4 | 10x Genomics | 5.91 Bn | 5.37 Bn | 106.18 Mn |
| 5 | Hinge Health | 5.90 Bn | 5.58 Bn | 154.23 Mn |
| 6 | MiniMed | 4.50 Bn | 4.21 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.43 Bn | 4.36 Bn | 216.84 Mn |
| 8 | Doximity | 3.91 Bn | 3.16 Bn | 125.97 Mn |
| 9 | Privia Health | 3.19 Bn | 2.77 Bn | - |
| 10 | SOPHiA GENETICS | 382.28 Mn | 311.99 Mn | 14.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5.11 Mn |
| Dec 31, 2020 | 3.25 Mn |